| Updated on March 24, 2015 Published on March 24, 2015

Caplin Point Laboratories Ltd has informed BSE that in connection with the approval of the Companys state of art sterile injectable facility (Unit IV) under European GMP, the Officials of EU GMP had carried out inspection of the unit recently. The outcome of the inspection is very positive and it is likely that the approval may be accorded shortly. The Company shall update upon receipt of the final communication from the said Authorities.

Source : BSE - www.bseindia.com

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on March 24, 2015
This article is closed for comments.
Please Email the Editor